CFG Wealth Management Services’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$85.6K Buy
+470
New +$102K 0.08% 77
2026
Q2
– Sell
-470
Closed -$79.4K – 91
2026
Q1
$79.4K Buy
+470
New +$81.2K 0.07% 81

Other funds holding AXSM

CFG Wealth Management Services's AXSM Position: Q3 2026 in Review

CFG Wealth Management Services opened a new position in Axsome Therapeutics (AXSM) in Q3 2026: 470 shares worth $85.6K. The stake represents 0.08% of the portfolio and ranks #77 among its holdings. This is a return to the name: CFG Wealth Management Services previously reported a position in AXSM as recently as Q1 2026.

CFG Wealth Management Services first reported a position in AXSM in Q1 2026 and has held it in 2 quarters since. 466 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.

  • CFG Wealth Management Services held 470 shares of Axsome Therapeutics worth $85.6K as of Q3 2026.
  • Axsome Therapeutics was a new CFG Wealth Management Services position in Q3 2026.
  • Axsome Therapeutics made up 0.08% of CFG Wealth Management Services's portfolio in Q3 2026, its #77 holding.
  • CFG Wealth Management Services first reported a position in Axsome Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 466 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.

Based on CFG Wealth Management Services's 13F filing for Q3 2026, filed 21 Oct 2026.